TMPRSS2 and prostate carcinoma: In addition, the presence of the TMPRSS2:ERG fusion protein could be detected by immunostaining with the rabbit monoclonal anti-ERG antibody [20] in fusion-positive vCaP prostate cancer cells captured by the device and analyzed by multiplex confocal microscopy (Figure S3).